RPID
Rapid Micro Biosystems Inc - Ordinary Shares - Class A

333
Mkt Cap
$175.52M
Volume
43,192.00
52W High
$4.50
52W Low
$0.87
PE Ratio
-3.97
RPID Fundamentals
Price
$3.81
Prev Close
$3.96
Open
$3.90
50D MA
$3.55
Beta
1.16
Avg. Volume
133,900.37
EPS (Annual)
-$1.08
P/B
3.96
Rev/Employee
$172,092.02
Loading...
Loading...
News
all
press releases
Rapid Micro Biosystems (NASDAQ:RPID) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered shares of Rapid Micro Biosystems from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·26d ago
News Placeholder
More News
News Placeholder
Rapid Micro Biosystems (NASDAQ:RPID) Releases Earnings Results, Hits Expectations
Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.26) earnings per share for the quarter, meeting analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Misses Revenue Estimates
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of 0.00% and -0.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Earnings Outlook For Rapid Micro Biosystems
read more...
Benzinga·1mo ago
News Placeholder
Teleflex (TFX) Q3 Earnings and Revenues Surpass Estimates
Teleflex (TFX) delivered earnings and revenue surprises of +8.58% and +2.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
U.S. Physical Therapy (USPH) Q3 Earnings Miss Estimates
U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of -1.49% and +1.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -3.85% and -0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Artivion (AORT) Tops Q2 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of +118.18% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
908 Devices (MASS) delivered earnings and revenue surprises of -12.50% and +7.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
Thermo Fisher (TMO) delivered earnings and revenue surprises of +2.68% and +1.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago

Latest RPID News

View

Advertisement|Remove ads.

Advertisement|Remove ads.